Table 1.
Characteristics of patients scheduled for neoadjuvant cancer treatment and surgery
| Exercise (n = 23) | Control (n = 10) | p value | |
|---|---|---|---|
| Age (year)* | 64 (45–82) | 72 (62–84) | 0.015 |
| Gender M:F (%) | 15 (65): 8 (35) | 8 (80): 2 (20) | 0.710 |
| Past medical historya | 10 (44) | 5 (50) | 0.617 |
| Heart failure | 3 (13) | 1 (10) | |
| Diabetes | 2 (9) | 1 (10) | |
| Ischaemic heart disease | 5 (22) | 3 (30) | |
| Cerebrovascular disease | 0 | 0 | |
| ASAb | 0.003 | ||
| I | 11 (48) | 0 | |
| II | 10 (44) | 9 (90) | |
| III | 2 (9) | 1 (10) | |
| WHO performance statusb | 0.035 | ||
| 0 | 18 (78) | 0 | |
| 1 | 5 (22) | 9 (90) | |
| 2 | 0 | 1 (10) |
Values presented as mean (range). Participants who dropped out of the study are not included in participant characteristics
aFrequencies with percentages in parentheses, smoking status assessed as currently smoking: yes (1) vs no (0)
bNumber of patients (%) WHO performance status and ASA physical status
*p < 0.05 was taken as statistically significant